Cargando…
Benzylic Dehydroxylation of Echinocandin Antifungal Drugs Restores Efficacy against Resistance Conferred by Mutated Glucan Synthase
[Image: see text] Each year, infections caused by fungal pathogens claim the lives of about 1.6 million people and affect the health of over a billion people worldwide. Among the most recently developed antifungal drugs are the echinocandins, which noncompetitively inhibit β-glucan synthase, a membr...
Autores principales: | Logviniuk, Dana, Jaber, Qais Z., Dobrovetsky, Roman, Kozer, Noga, Ksiezopolska, Ewa, Gabaldón, Toni, Carmeli, Shmuel, Fridman, Micha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991007/ https://www.ncbi.nlm.nih.gov/pubmed/35347986 http://dx.doi.org/10.1021/jacs.2c00269 |
Ejemplares similares
-
Elevated Vacuolar Uptake of Fluorescently Labeled
Antifungal Drug Caspofungin Predicts Echinocandin Resistance in Pathogenic
Yeast
por: Jaber, Qais Z., et al.
Publicado: (2020) -
Echinocandins Localized to the Target-Harboring Cell
Surface Are Not Degraded but Those Entering the Vacuole Are
por: Jaber, Qais Z., et al.
Publicado: (2022) -
Comparison of echinocandin antifungals
por: Eschenauer, Gregory, et al.
Publicado: (2007) -
Novel Cell Wall Antifungals Reveal a Special Synergistic Activity in pbr1 Mutants Resistant to the Glucan Synthesis Antifungals Papulacandins and Echinocandins
por: Berzaghi, Rodrigo, et al.
Publicado: (2019) -
Echinocandin-Induced Microevolution of Candida parapsilosis Influences Virulence and Abiotic Stress Tolerance
por: Papp, Csaba, et al.
Publicado: (2018)